DOCSLIB.ORG

Pediatric Ophthalmology 2018 Winds of Change in the Windy City

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pediatric Ophthalmology 2018 Winds of Change in the Windy City Pediatric Ophthalmology 2018 Winds of Change in the Windy City Program Directors Jonathan M Holmes MD and Scott A Larson MD In conjunction with the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics McCormick Place Chicago, Illniois Saturday, Oct. 27, 2018 Presented by: The American Academy of Ophthalmology Pediatric Ophthalmology Subspecialty Day Advisory Committee Staff 2018 Planning Group Daniel S Durrie MD Melanie R Rafaty CMP DES, Director, Jonathan M Holmes MD Associate Secretary Scientific Meetings Program Director Julia A Haller MD Ann L’Estrange, Subspecialty Day Manager Scott A Larson MD Michael S Lee MD Carolyn Little, Presenter Coordinator Program Director Francis S Mah MD Debra Rosencrance CMP CAE, Vice President, Meetings & Exhibits Erick D Bothun MD R Michael Siatkowski MD Kuldev Singh MD MPH Patricia Heinicke Jr, Copy Editor Yasmin S Bradfield MD Mark Ong, Designer Michael F Chiang MD Maria M Aaron MD Gina Comaduran, Cover Designer Nils K Mungan MD Secretary for Annual Meeting Serena X Wang MD Tammy L Yanovitch MD ©2018 American Academy of Ophthalmology. All rights reserved. No portion may be reproduced without express written consent of the American Academy of Ophthalmology. ii Planning Group 2018 Subspecialty Day | Pediatric Ophthalmology 2018 Pediatric Ophthalmology Subspecialty Day Planning Group On behalf of the American Academy of Ophthalmology, the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), and the American Academy of Pediatrics (AAP), it is our pleasure to welcome you to Chicago and Pediatric Ophthalmology 2018: Winds of Change in the Windy City. Jonathan M Holmes MD Scott A Larson MD Program Director Program Director National Institutes of Health: S None Erick D Bothun MD Yasmin S Bradfield MD Michael F Chiang MD None None Clarity Medical Systems (unpaid Board): C Inteleretina: O National Eye Institute: S National Science Foundation: S Novartis Pharmaceuticals Corp.: C 2018 Subspecialty Day | Pediatric Ophthalmology Planning Group iii No photo No photo available available Nils K Mungan MD Serena X Wang MD Tammy L Yanovitch MD None None None 2018 Subspecialty Francis S Mah MD Kuldev Singh MD MPH (Cornea) (Glaucoma) Day Advisory Abbott Medical Optics Aerie: C Inc.: C,L,S Alcon Laboratories Inc.: C Committee Aerie: C | Alcon: C Allergan: C Allergan: C Belkin Laser Ltd.: C Daniel S Durrie MD, Chair Avedro, Inc.: C Glaukos Corp.: C (Refractive Surgery) Avellino Labs: C InjectSense: C | Ivantis: C AcuFocus Inc.: C,L,O Bausch Lomb: C,L Johnson & Johnson: C Alcon Laboratories Inc.: S CoDa: C | EyePoint: C Mynosys: C Alphaeon: C,O inVirsa: C | iView: C National Eye Institute: S Avedro: C,L,O KALA: C Novartis Institute for Biomedical Concierge Key Health: C,O Mallinckrodt Pharmaceuticals: C Research: C Eyedetec Medical Inc.: C NovaBay: C Ocular Therapeutix Inc.: C Eyegate Pharma: C Novartis, Alcon Pharmaceuticals: Santen Inc.: C | Shire: C Hoopes Durrie Rivera Research C,L Thieme Medical Publishers: C Center: C Ocular Science: C,O U.S. Food and Drug Johnson & Johnson Vision: C,L Ocular Therapeutix: C,S Administration: C,S Strathspey Crown LLC: C,O Okogen: C,O Omeros Corporation: C Julia A Haller MD PolyActiva: C (Retina) AAO Staff RxSight: C Aura Biosciences: C Senju: S | Shire: C,L Celgene: O | KalVista: C Ann L’Estrange Slack Publishing: C,P Lowy Medical Research None Sun Pharma: C,L Institute: C Sydnexis: C,O Novartis Pharmaceuticals Carolyn Little TearLab: C Corp.: C None Spark Therapeutics: C R Michael Siatkowski MD Melanie Rafaty Michael S Lee MD (Pediatric Ophthalmology) None National Eye Institute: S (Neuro-Ophthalmology) National Eye Institute: S Debra Rosencrance Quark Pharmaceuticals: S None Springer: P Uptodate: P Beth Wilson None 2018 Subspecialty Day | Pediatric Ophthalmology Contents v Pediatric Ophthalmology 2018 Contents Program Planning Group ii CME vi Faculty Listing viii How to Use the Audience Interaction Application xii Program Schedule xiii Section I: Weathering the Storm—Surgical Approaches to Vertical Strabismus 1 Section II: Sudden Showers—Late Breaking RCTs and Observational Studies 13 Section III: Raining Cats and Dogs—Challenges of Applying Evidence-Based Medicine 19 Section IV: Ice Breaker—What Our Adult Specialty Colleagues Can Teach Us 27 Advocating for the Profession and Patients 35 Section V: Here Comes the Sun—Myopia Prevention 35 Section VI: London Fog—What Am I Doing Differently in Pediatric Anterior Segment 44 Section VII: Electrical Storm—Imaging in Pediatric Ophthalmology 49 Faculty Financial Disclosure 55 Presenter Index 58 vi CME 2018 Subspecialty Day | Pediatric Ophthalmology CME Credit The Academy’s CME Mission Statement Scientific Integrity and Disclosure of Conflicts of Interest The purpose of the American Academy of Ophthalmology’s Continuing Medical Education (CME) program is to present The American Academy of Ophthalmology is committed to ophthalmologists with the highest quality lifelong learning ensuring that all CME information is based on the application opportunities that promote improvement in physician practices, of research findings and the implementation of evidence-based resulting in the best possible eye care for their patients. medicine. It seeks to promote balance, objectivity, and absence of commercial bias in its content. All persons in a position to control the content of this activity must disclose any and all 2018 Pediatric Ophthalmology Subspecialty Day financial interests. The Academy has mechanisms in place to Learning Objectives resolve all conflicts of interest prior to an educational activity This meeting will enable attendees to: being delivered to the learners. The Academy requires all presenters to disclose on their first ■ Improve their ability to diagnose and manage pediatric slide whether they have any financial interests from the past 12 ophthalmology and strabismus conditions months. Presenters are required to verbally disclose any finan- ■ Improve their outcomes in the management of pediatric cial interests that specifically pertain to their presentation. ophthalmology and strabismus conditions ■ Integrate new and existing clinical trial results into their management of childhood eye disease Control of Content ■ Apply new adult ophthalmology subspecialty develop- The American Academy of Ophthalmology considers present- ments to the care of children ing authors, not coauthors, to be in control of the educational ■ Apply the recent developments in therapeutic approaches content. It is Academy policy and traditional scientific pub- to reducing myopia progression lishing and professional courtesy to acknowledge all people ■ Use emerging developments in childhood anterior seg- contributing to the research, regardless of CME control of ment disease the live presentation of that content. This acknowledgment ■ Apply new imaging and testing modalities in their care of is made in a similar way in other Academy CME activities. children with eye conditions and patients with strabismus Though coauthors are acknowledged, they do not have control of the CME content, and their disclosures are not published or 2018 Pediatric Ophthalmology Subspecialty Day resolved. Target Audience The intended target audience for this program is pediatric Attendance Verification for CME Reporting ophthalmologists, comprehensive ophthalmologists, medical Before processing your requests for CME credit, the American professionals, visual physiologists, and orthoptists who are Academy of Ophthalmology must verify your attendance at involved in maintaining high-quality health care for the pediat- Subspecialty Day and/or AAO 2018. In order to be verified for ric and strabismus populations. CME or auditing purposes, you must either: ■ Register in advance, receive materials in the mail, and 2018 Pediatric Ophthalmology Subspecialty Day turn in the Subspecialty Day Syllabi exchange voucher(s) CME Credit onsite; The American Academy of Ophthalmology is accredited by ■ Register in advance and pick up your badge onsite if the Accreditation Council for Continuing Medical Education materials did not arrive before you traveled to the meet- (ACCME) to provide CME for physicians. ing; The American Academy of Ophthalmology designates this ■ Register onsite; or live activity for a maximum of 7 AMA PRA Category 1 Cred- ■ Scan the barcode on your badge as you enter an AAO its™. Physicians should claim only the credit commensurate 2018 course or session room. with the extent of their participation in the activity. CME Credit Reporting Teaching at a Live Activity South Building Level 2.5 and Academy Resource Center Teaching instruction courses or delivering a scientific paper or Attendees whose attendance has been verified (see above) at poster is not an AMA PRA Category 1 Credit™ activity and AAO 2018 can claim their CME credit online during the meet- should not be included when calculating your total AMA PRA ing. Registrants will receive an email during the meeting with Category 1 Credits™. Presenters may claim AMA PRA Cat- the link and instructions on how to claim credit. egory 1 Credits™ through the American Medical Association. Onsite, you may report credits earned during Subspecialty To obtain an application form please contact the AMA at Day and/or AAO 2018 at the CME Credit Reporting booth. www.ama-assn.org. 2018 Subspecialty Day | Pediatric Ophthalmology CME vii Academy Members Proof of Attendance The CME credit reporting receipt is not a CME transcript. The following types of attendance verification
Load more

Recommended publications
  • A Patient & Parent Guide to Strabismus Surgery
    A Patient & Parent Guide to Strabismus Surgery By George R. Beauchamp, M.D. Paul R. Mitchell, M.D. Table of Contents: Part I: Background Information 1. Basic Anatomy and Functions of the Extra-ocular Muscles 2. What is Strabismus? 3. What Causes Strabismus? 4. What are the Signs and Symptoms of Strabismus? 5. Why is Strabismus Surgery Performed? Part II: Making a Decision 6. What are the Options in Strabismus Treatment? 7. The Preoperative Consultation 8. Choosing Your Surgeon 9. Risks, Benefits, Limitations and Alternatives to Surgery 10. How is Strabismus Surgery Performed? 11. Timing of Surgery Part III: What to Expect Around the Time of Surgery 12. Before Surgery 13. During Surgery 14. After Surgery 15. What are the Potential Complications? 16. Myths About Strabismus Surgery Part IV: Additional Matters to Consider 17. About Children and Strabismus Surgery 18. About Adults and Strabismus Surgery 19. Why if May be Important to a Person to Have Strabismus Surgery (and How Much) Part V: A Parent’s Perspective on Strabismus Surgery 20. My Son’s Diagnosis and Treatment 21. Growing Up with Strabismus 22. Increasing Signs that Surgery Was Needed 23. Making the Decision to Proceed with Surgery 24. Explaining Eye Surgery to My Son 25. After Surgery Appendix Part I: Background Information Chapter 1: Basic Anatomy and Actions of the Extra-ocular Muscles The muscles that move the eye are called the extra-ocular muscles. There are six of them on each eye. They work together in pairs—complementary (or yoke) muscles pulling the eyes in the same direction(s), and opposites (or antagonists) pulling the eyes in opposite directions.
    [Show full text]
  • Pediatric Ophthalmology/Strabismus 2017-2019
    Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Pediatric Ophthalmology/Strabismus *** Pediatric Ophthalmology/Strabismus 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law.
    [Show full text]
  • Pediatric Cataracts: a Retrospective Study of 12 Years (2004
    Pediatric Cataracts: A Retrospective Study of 12 Years (2004 - 2016) Cataratas em Idade Pediátrica: Estudo Retrospetivo de 12 ARTIGO ORIGINAL Anos (2004 - 2016) Jorge MOREIRA1, Isabel RIBEIRO1, Ágata MOTA1, Rita GONÇALVES1, Pedro COELHO1, Tiago MAIO1, Paula TENEDÓRIO1 Acta Med Port 2017 Mar;30(3):169-174 ▪ https://doi.org/10.20344/amp.8223 ABSTRACT Introduction: Cataracts are a major cause of preventable childhood blindness. Visual prognosis of these patients depends on a prompt therapeutic approach. Understanding pediatric cataracts epidemiology is of great importance for the implementation of programs of primary prevention and early diagnosis. Material and Methods: We reviewed the clinical cases of pediatric cataracts diagnosed in the last 12 years at Hospital Pedro Hispano, in Porto. Results: We identified 42 cases of pediatric cataracts with an equal gender distribution. The mean age at diagnosis was 6 years and 64.3% of patients had bilateral disease. Decreased visual acuity was the commonest presenting sign (36.8%) followed by leucocoria (26.3%). The etiology was unknown in 59.5% of cases and there was a slight predominance of nuclear type cataract (32.5%). Cataract was associated with systemic diseases in 23.8% of cases and with ocular abnormalities in 33.3% of cases. 47.6% of patients were treated surgically. Postoperative complications occurred in 35% of cases and posterior capsular opacification was the most common (25%). Discussion: The report of 42 cases is probably the result of the low prevalence of cataracts in this age. Although the limitations of our study include small sample size, the profile of children with cataracts in our hospital has characteristics relatively similar to those described in the literature.
    [Show full text]
  • Pediatric Glaucoma
    CLINICAL STRATEGIES Pediatric Glaucoma Advice on diagnosing and managing a rare but potentially devastating group of diseases. BY SHARON F. FREEDMAN, MD hildhood glaucomas are infrequently encoun- try between the corneas of the infant’s eyes. Rapid corneal tered by many eye care providers and can there- stretching may lead to breaks in Descemet’s membrane fore be challenging to diagnose. Because this het- called Haab’s striae, which will leave permanent scars Cerogeneous group of diseases can cause a rapid (Figure 1). Oftentimes, the affected infant is photophobic loss of vision or even blindness, however, the timely recog- (Figure 2) and may have tearing that the clinician must dis- nition and optimal treatment of pediatric glaucoma is criti- tinguish from nasolacrimal duct obstruction.1,2 cal. Fortunately, ophthalmologists often have at their dis- Newborns with healthy eyes have a corneal diameter of posal the tools needed to diagnose and begin to manage approximately 9.5 to 10.0 mm. A corneal diameter of these children. Usually, the ideal care of patients with pedi- greater than 12.0 mm in any infant younger than 1 year is atric glaucoma involves the efforts of more than one oph- therefore suspicious for glaucoma.3 The IOP usually thalmologist, unless a pediatric glaucoma specialist is locat- ranges from 10 to 15 mm Hg in newborns, whereas the ed near the child’s home. IOP in children of school age resembles that of adults. Most children with glaucoma will have an IOP that is BACKGROUND higher than 22 mm Hg. The most common form of pediatric glaucoma, primary Although infants and children under the age of 2 often congenital glaucoma, occurs in approximately one in present with signs and symptoms related to rapid ocular 10,000 individuals.1 As with adult forms of the disease, expansion under high IOP, older children without an acute- pediatric glaucoma may be primary or secondary.
    [Show full text]
  • AAPOS – SPOSI Joint Meeting, Jaipur, India, Preliminary Program – Subject to Changes
    AAPOS – SPOSI Joint Meeting, Jaipur, India, Preliminary Program – Subject to changes Friday, December 2, 2016 9:00 AM – 9:05 AM Opening Remarks & Welcome Room A and Room B Sean P. Donahue, MD, PhD 9:05 AM – 10:35 AM Childhood Visual Impairment: Detection, Assessment, and Rehabilitation Room A and Room B 9:05 AM – 9:41 AM Blindness and Prevention of Visual Impairment in Children 9:05 AM – 9:06 AM Introduction Sherwin J. Isenberg, MD 9:06 AM – 9:24 AM Childhood Blindness World Wide: Current Status Clare Gilbert, MB ChB, FRCOphth, MD, MSc 9:24 AM – 9:32 AM The NGO’s Role in Treating and Preventing Blindness Marilyn T. Miller, MD Victoria Sheffield, President and CEO, International Eye Foundation 9:32 AM – 9:38 AM Epidemiology of Eye Disease in Children Birth to 3 in a Tertiary Eye Center in India P. Vijayalakshmi, MS, DO 9:38 AM – 9:41 AM Question and Answer Session 9:41 AM – 10:06 AM Early Detection and Assessment of Visual Impairment in Children 9:41 AM – 9:42 AM Introduction Linda Lawrence, MD 9:42 AM – 9:57 AM How the Pediatric Ophthalmologist Diagnoses CVI and Why? Gordon Dutton, MD, FRCS Ed (hon), FRCOphth 9:57 AM – 10:03 AM Early Detection Should Lead to Early Intervention; Rural Initiatives Kalpana Narendran, MBBS, DO, DNB 10:03 AM – 10:06 AM Question and Answer Session 10:06 AM – 10:35 AM Rehabilitation for Children with Visual Impairment 10:06 AM – 10:07 AM Introduction Albert Biglan, MD 10:07 AM – 10:17 AM Interventions from the Ophthalmologist’s Perspective Lea Hyvärinen, MD, PhD 10:17 AM – 10:25 AM Interventions from the Rehabilitation
    [Show full text]
  • Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population
    CPJXXX10.1177/0009922820916892Clinical PediatricsLin et al 916892research-article2020 Article Clinical Pediatrics 2020, Vol. 59(8) 760 –765 Abnormal Red Reflex: Etiologies in a © The Author(s) 2020 Article reuse guidelines: sagepub.com/journals-permissions Pediatric Ophthalmology Population DOI:https://doi.org/10.1177/0009922820916892 10.1177/0009922820916892 journals.sagepub.com/home/cpj Sophie Y. Lin, BA1 , Kimberly G. Yen, MD1,2, Huirong Zhu, PhD2, Alexis Moisiuc, BS2, and Madhuri Chilakapati, MD1,2 Abstract Children who present with an abnormal red reflex (ARR) are often referred to ophthalmology due to concern for retinoblastoma. However, an ARR can indicate a wide variety of pathologies, all of which have the potential to develop amblyopia and irreversible vision loss. In this retrospective cohort study, we demonstrate that children who presented with an ARR had a mean age of 22.0 ± 32.5 months and were more frequently referred by their pediatricians (74.5%). The majority of these patients (61.8%) had a normal examination on further evaluation, followed by refractive error (20.4%). Amblyopia was diagnosed in 83.9% of patients with refractive error, with a mean age of 50.3 ± 49.2 months. Because many ARR-associated pathologies require time-sensitive treatment to prevent vision loss, proper screening is critical for diagnosis. Pediatricians play a key role in screening, so education on more common ARR pathologies can better facilitate referrals and improve outcomes. Keywords abnormal red reflex, leukocoria, screening Introduction to any ocular condition that limits visual stimulation to the eye so if amblyopia is not treated early, vision loss Eliciting the red reflex is a useful clinical test used by can be irreversible.
    [Show full text]
  • Update on Orthokeratology in Managing Progressive Myopia in Children: Efficacy, Mechanisms, and Concerns
    Review Article Update on Orthokeratology in Managing Progressive Myopia in Children: Efficacy, Mechanisms, and Concerns Xintong Li, MD; Ilana B. Friedman, MD; Norman B. Medow, MD; Cheng Zhang, MD ABSTRACT INTRODUCTION Myopia is an important public health issue, and high my- Myopia, commonly known as near-sightedness, opia may lead to severe complications if left untreated. is a spherical refractive error that causes light to fo- Orthokeratology lenses, worn overnight to reshape the cus in front of the retina, resulting in blurry distance cornea, are one of many recent modalities used to slow vision while preserving clearer near vision. It is due down the progression of myopia in children. This treat- to axial lengthening of the globe or increased refrac- ment has been proven successful, as evidenced by de- tive power of the eye. Epidemiologic studies of this creased spherical refractive error and axial length relative condition are complicated by age, ethnicity, and the to the control at interval follow-up ranging from 6 months degree of spherical refractive error needed to label an to 5 years. In this systematic review, the authors collected eye as myopic, and its prevalence ranges from 33% published controlled studies that analyzed the efficacy in whites to approximately 90% in East Asians. In of orthokeratology lens wear and calculated longitudi- addition to increasing functional impairment of nal relative changes in axial length, revealing a weighted the patient, myopia increases the risk of subretinal average of -45.1% change in
    [Show full text]
  • Retinopathy of Prematurity
    INVITED COMMENTARY Retinopathy of Prematurity Alice L. Bashinsky Retinopathy of prematurity (ROP) is a vasoproliferative 90% experience spontaneous regression, and between retinal disorder unique to premature infants. As premature 1,100 and 1,500 develop disease severe enough to require births increase in many areas of the world, ROP has become medical treatment [7]. The Cryotherapy for Retinopathy of a leading cause of childhood blindness. A better understand- Prematurity (CRYO-ROP) Cooperative Group determined ing of the pathogenesis of ROP, adherence to strict screening that ROP occurred in 66% of infants with a birth weight of guidelines, and evolution of treatment options have reduced 1,250 g or less and in 82% of infants with a birth weight of the number of sight-threatening complications from ROP. less than 1,000 g [3]. Despite appropriate medical interven- tions, 400 to 600 infants each year in the United States become legally blind from ROP [7]. etinopathy of prematurity (ROP) is a disorder of reti- Gestational age and birth weight, the two greatest risk Rnal blood vessel development in low birth weight pre- factors for ROP, are inversely correlated with the develop- term infants and is the second leading cause of childhood ment of ROP. Specifically, smaller babies and those born at blindness in the United States behind cortical visual impair- an earlier gestational age are at higher risk. Between 1986 ment [1]. ROP is a complex disease process initiated in part and 2013, the birth weight and gestational age of infants by a lack of complete retinal vascularization in premature enrolled in ROP studies in the United States decreased, infants.
    [Show full text]
  • Procedures for the Evaluation of the Visual System by Pediatricians Sean P
    CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care Procedures for the Evaluation of the Visual System by Pediatricians Sean P. Donahue, MD, PhD, FAAP, Cynthia N Baker, MD, FAAP, COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE, SECTION ON OPHTHALMOLOGY, AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS, AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, AMERICAN ACADEMY OF OPHTHALMOLOGY Vision screening is crucial for the detection of visual and systemic disorders. It abstract should begin in the newborn nursery and continue throughout childhood. This clinical report provides details regarding methods for pediatricians to use for screening. This clinical report supplements the combined policy statement from the American Academy of Pediatrics (AAP), American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology, and American Association of Certified Orthoptists titled “Visual System Assessment in Infants, Children, and Young Adults by Pediatricians.”1 The clinical report and accompanying policy statement supplant the 2012 policy statement “Instrument-Based Pediatric Vision Screening,”2 the 2003 policy statement “Eye Examination in Infants, Children, and Young Adults by Pediatricians,”3 and the 2008 AAP policy statement “Red Reflex Examination in Neonates Infants and Children.”4 The policy statement This document is copyrighted and is property of the American articulates the screening criteria and screening methods, and the clinical Academy of Pediatrics and its Board of Directors. All authors have filed report explains the various evaluation procedures that are available for conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process use by the pediatrician or primary care physician. approved by the Board of Directors.
    [Show full text]
  • Management of Retinopathy of Prematurity in a Neonatal Unit
    [Downloaded free from http://www.jcnonweb.com on Thursday, October 31, 2019, IP: 181.64.200.181] Review Article Management of Retinopathy of Prematurity in a Neonatal Unit: Current Approach Hussain Parappil1,2, Anant Pai3, Nazla Abdelmonem Mahmoud1, Mohammad Ayman AlKhateeb1,2, Hilal Al Rifai1,2, Maha Mohammed El Shafei3 1 Department of Neonatology, Retinopathy of prematurity (ROP) is a blinding morbidity affecting preterm Women’s Wellness and infants. It currently represents the leading preventable cause of childhood blindness Research Centre, Hamad Medical Corporation, worldwide. Most data indicate an increasing incidence of ROP disease in both 2Department of Pediatrics, industrialized countries and in the developing world. There are neither symptoms Abstract Weill Cornell Medical of ROP nor can a specific visual behavior in a preterm infant herald a concern for College, 3Department of ROP. Hence, an effective screening is essential for prompt diagnosis of ROP. The Ophthalmology, Hamad available evidence suggests that the majority of premature infants who go blind Medical Corporation, Doha, from ROP do so due to screening failure. Timely screening of premature infants at Qatar risk is as important as early treatment in the management of ROP. The screening protocol at each neonatal intensive care unit (NICU) should be evidence‑based, should be based on preferences of neonatologists, ophthalmologists, and NICU nurses. All at‑risk infants should be identified and receive adequate dilated retinal examinations at appropriate times. Appropriate screening and follow‑up guidelines and timely treatment protocols need to be implemented in every NICU by pediatricians and ophthalmologists to reduce the ROP‑related blindness in the community.
    [Show full text]
  • And Strabismus Second Edition Springer Science+Business Media, LLC Pediatric Ophthalmology and Strabismus Second Edition
    The following tables can be used as a guideline in planning Strabismus surgery. These numbers have been derived from Marshall Parks, with modifications from the surgical experience of Kenneth W. Wright. The numbers are only a guide and should be modified as necessary. BINOCULAR SURGERY Esotropia MROU LR OU ET Recession ET Resection* 1S~ 3.0mm 1S~ 3.Smm 20~ 3.Smm 20~ 4.Smm 2S~ 4.0mm 2S~ S.Smm 30~ 4.Smm 30~ 6.0mm 3S~ S.Omm 3S~ 6.Smm 40~ S.Smm 40~ 7.0mm so~ 6.0mm so~ 8.0mm 60~ 6.Smm 70~ 7.0mm * When a lateral rectus resection is clone for residual esotropia after large medial rectus recession (6.00 mm or larger), these numbers should be lowered. Exotropia LR OU MROU XT Recession XT Resection 1S~ 4.0mm 1S~ 3.0mm 20~ S.Omm 20~ 4.0mm 2S~ 6.0mm 2S~ S.Omm 30~ 7.0mm 30~ S.Smm 3S~ 7.Smm 3S~ 6.0mm 40~ 8.0mm 40~ 6.Smm so~ 9.0mm MONOCULARSURGERY Esotropia Exotropia MR LR LR MR ET Recession Resection XT Resection Resection 1S~ 3.0 mm ............... 3.S mm 1S~ 4.0 mm ................ 3.0 mm 20~ 3.S mm ............... 4.0 mm 20~ S.O mm ................ 4.0 mm 2S~ 4.0 mm ............... S.O mm 2S~ 6.0 mm ................ 4.S mm 30~ 4.S mm ............... S.S mm 30~ 6.S mm ................ S.O mm 3S~ S.O mm ............... 6.0 mm 3S~ 7.0 mm ................ S.S mm 40~ S.S mm ..............
    [Show full text]
  • What's New and Important in Pediatric Ophthalmology and Strabismus In
    What’s New and Important in Pediatric Ophthalmology and Strabismus in 2021 Complete Unabridged Handout AAPOS Virtual Meeting April 2021 Presented by the AAPOS Professional Education Committee Tina Rutar, MD - Chairperson Austin E Bach, DO Kara M Cavuoto, MD Robert A Clark, MD Marina A Eisenberg, MD Ilana B Friedman, MD Jennifer A Galvin, MD Michael E Gray, MD Gena Heidary, MD PhD Laryssa Huryn, MD Alexander J Khammar MD Jagger Koerner, MD Eunice Maya Kohara, DO Euna Koo, MD Sharon S Lehman, MD Phoebe Dean Lenhart, MD Emily A McCourt, MD - Co-Chairperson Julius Oatts, MD Jasleen K Singh, MD Grace M. Wang, MD PhD Kimberly G Yen, MD Wadih M Zein, MD 1 TABLE OF CONTENTS 1. Amblyopia page 3 2. Vision Screening page 12 3. Refractive error page 20 4. Visual Impairment page 31 5. Neuro-Ophthalmology page 37 6. Nystagmus page 48 7. Prematurity page 52 8. ROP page 55 9. Strabismus page 65 10. Strabismus surgery page 82 11. Anterior Segment page 101 12. Cataract page 108 13. Cataract surgery page 110 14. Glaucoma page 120 15. Refractive surgery page 127 16. Genetics page 128 17. Trauma page 151 18. Retina page 156 19. Retinoblastoma / Intraocular tumors page 167 20. Orbit page 171 21. Oculoplastics page 175 22. Infections page 183 23. Pediatrics / Infantile Disease/ Syndromes page 186 24. Uveitis page 190 25. Practice management / Health care systems / Education page 192 2 1. AMBLYOPIA Self-perception in Preschool Children With Deprivation Amblyopia and Its Association With Deficits in Vision and Fine Motor Skills. Birch EE, Castaneda YS, Cheng-Patel CS, Morale SE, Kelly KR, Wang SX.
    [Show full text]